UnitedHealth Group's stock continues to decline as the insurer battles rising medical costs and a challenging earnings outlook. Following the abrupt CEO change, the company anticipates no earnings growth until 2026.
UnitedHealth Group's upcoming earnings report has sparked intense social media buzz as its stock faces a dramatic decline. Analysts weigh in on the potential for recovery or a value trap amid industry challenges.
UnitedHealth Group faces a crisis with a cyberattack, federal investigations, and a leadership change. Can new CEO Stephen Hemsley restore investor confidence and improve profits?
After a steep 18% drop, UnitedHealth Group's shares saw a modest rebound as analysts maintain positive ratings despite the company withdrawing its guidance and the CEO's resignation. Will the stock recover?
In a shocking turn of events, Andrew Witty has resigned as CEO of UnitedHealth Group, triggering a 17% stock drop and raising concerns over the company's future amid rising medical costs and a recent antitrust lawsuit.
In a surprising move, UnitedHealth Group CEO Andrew Witty has stepped down, citing personal reasons. Board chairman Stephen Hemsley takes over as the company navigates significant industry challenges.
In a surprising turn of events, UnitedHealth Group announces a new CEO as Andrew Witty steps down. Stephen Hemsley returns to lead amid stock market challenges and ongoing scrutiny over corporate practices.
UnitedHealth Group's shares plummeted 23% in midday trading following a rare earnings miss, erasing nearly $120 billion in market value due to unexpected medical costs and higher care utilization.
